Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O J Finn

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Immuno-oncology: understanding the function and dysfunction of the immune system in cancerO J Finn
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J Finn
Current Opinion in Immunology|October 1, 1993
Tumor-rejection antigens recognized by T lymphocytesO J Finn
Clinical Immunology and Immunopathology|June 1, 1994
Tumor-specific immune responses and opportunities for tumor vaccinesO J Finn
Important Advances in Oncology|January 1, 1992
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapyO J Finn
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapyP Ciborowski, O J Finn
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cellsG Pecher, O J Finn
Cell Death and Differentiation|November 17, 2007
T-cell death and cancer immune toleranceB Lu, O J Finn
Cancer Research|June 19, 2001
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patientsJ Schmielau, O J Finn
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2000
Expression of MUC1 in insect cells using recombinant baculovirusP Ciborowski, O J Finn
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2012
Immuno-oncology: understanding the function and dysfunction of the immune system in cancerO J Finn
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Antigen-specific, MHC-unrestricted T cellsO J Finn
Current Opinion in Immunology|October 1, 1993
Tumor-rejection antigens recognized by T lymphocytesO J Finn
Clinical Immunology and Immunopathology|June 1, 1994
Tumor-specific immune responses and opportunities for tumor vaccinesO J Finn
Important Advances in Oncology|January 1, 1992
Pancreatic tumor antigens: diagnostic markers and targets for immunotherapyO J Finn
Biomedical Peptides, Proteins & Nucleic Acids : Structure, Synthesis & Biological Activity|January 1, 1995
Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapyP Ciborowski, O J Finn
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cellsG Pecher, O J Finn
Cell Death and Differentiation|November 17, 2007
T-cell death and cancer immune toleranceB Lu, O J Finn
Cancer Research|June 19, 2001
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patientsJ Schmielau, O J Finn
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2000
Expression of MUC1 in insect cells using recombinant baculovirusP Ciborowski, O J Finn
Pageof 10